Physician profile
John E Drake
NPI 1265431589
$1,156.63
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $481 · 2020: $79.62 · 2021: $319 · 2022: $277.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $310.45 | 2019-2021 | |
| Lupin INC. | $265.52 | 2019-2021 | |
| Aspira Women'S Health INC | $179.87 | 2021-2022 | |
| Amgen INC. | $96.03 | 2022 | |
| Merck Sharp & Dohme LLC | $65.18 | 2019-2020 | |
| Organon LLC | $37.68 | 2021-2022 | |
| Exeltis, USA INC. | $31.39 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $28.19 | 2021-2022 | |
| Coopersurgical, INC. | $25.66 | 2019-2020 | |
| Hologic Sales and Service, LLC | $20.64 | 2019 | |
| Mayne Pharma Commercial LLC | $20.42 | 2022 | |
| Myovant Sciences INC. | $18.95 | 2022 | |
| Ethicon US, LLC | $15.59 | 2019 | |
| Pfizer INC. | $14.38 | 2022 | |
| Duchesnay USA Incorporated | $13.47 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $13.21 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Drake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.